Correlation Between Minimum Inhibitory Concentration and Clinical Outcome of Invasive Fusariosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04982159

Enrollment

Registered

2021-07-29

Start date

2020-01-01

Completion date

2020-12-31

Last updated

2022-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Fusariosis

Keywords

invasive fusariosis, minimum inhibitory concentration

Brief summary

Multi-centered, international, observational and retrospective study to analyze the correlation between MIC and clinical outcome in patients with invasive fusariosis.

Interventions

OTHERThere is no intervention. This is an observational study.

There is no intervention. This is an observational study.

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Invasive fusariosis diagnostic * Proof of anti-fungic susceptibility according to EUCAST or CLSI, for the medicine used in the treatment of invasive fusariosis. * Available data about anti-fungic medicines used: name of medicine, start and end date of treatment. * Available information about clinical outcome of illness after 30 days, 6 weeks and 90 days (dead or alive). * Only cases of invasive fusariosis proven or possible will be included.

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Clinical Evolution	6 weeks after diagnosis	Retrospective evaluation of death rate.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026